DG vs MDGL · P/E 15, rev $22.08B vs rev $675.6M
Dollar General Corporation (DG) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
DG currently screens at market cap $22.87B and trailing P/E 14.7. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the DG and MDGL stock pages for the full models.
Not investment advice.